Jed Gorlin, MD, MBA, vice president of medical and quality affairs at New York Blood Center Enterprises (NYBCe), and medical director for Memorial Blood Centers, Nebraska Community Blood Bank and Community Blood Center of Greater Kansas City,
retired from his roles within the organization July 1. His retirement marks the end of 28 years of dedicated service to Memorial Blood Centers.
He will continue to serve part time in his roles as medical director, transfusion service, at Children’s Minnesota; co-director of the transfusion service at Hennepin County Medical Center; and chief medical officer of America’s Blood Centers.
A pillar of the AABB community for many years, Gorlin has held numerous leadership roles in blood banking and transfusion medicine. He is a past member of the AABB Board of Directors and the AABB Foundation Board of Directors, as well as co-leader of the AABB Thursday Forum, a weekly call that focuses on critical topics in blood banking and transfusion medicine.
Gorlin has also served on more than 30 AABB committees, including as chair of AABB’s Transfusion Transmitted Diseases Committee, where he played a leading role in helping the blood community expand donor eligibility through individual donor assessment and in updating the
AABB Emerging Infectious Diseases Fact Sheets. Gorlin was also the inaugural chair of the Global Standards Committee, which developed the first edition of
Fundamental Standards for Blood Collection and Transfusion. In recognition of his service to AABB and the field, he received the John Elliott Memorial Award in 2019 and an AABB President’s Award in 2022.
Outside of AABB, Gorlin served as a member of the Food and Drug Administration’s Advisory Committee on Blood and Tissue Safety and Availability. He also worked as a consultant on AABB-PEPFAR projects in Rwanda and Tanzania and supported national blood development programs in Afghanistan, Kazakhstan and Kyrgyzstan through work with the Centers for Disease Control and Prevention.
“Dr. Gorlin’s passion for blood banking, transfusion medicine and AABB has made a real difference in the lives of patients around the world,” said Claudia S. Cohn, MD, PhD, chief medical officer at AABB. “His impact on the field, and on all of us lucky enough to work with him, cannot be overstated. His legacy will continue to guide and inspire us.”
